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Several ion channels are thought to facilitate colorectal afferent neuron sensitization, which 
contributes to abdominal pain in irritable bowel syndrome (IBS). In the present work, I 
hypothesized that two such channels – TRPV1 and P2X3 – cooperate to mediate colorectal pain 
and hypersensitivity. To test this, I employed TRPV1-P2X3 double knockout (TPDKO) mice 
and pharmacological antagonists and evaluated combined channel contributions to whole- 
organism responses to colorectal distension (CRD) and afferent fiber responses to colorectal 
stretch. Baseline responses to CRD were unexpectedly greater in TPDKO compared with control 
mice, but zymosan-produced CRD hypersensitivity was absent in TPDKO mice. Relative to 
control mice, proportions of afferent mechano-sensitive and -insensitive classes were not 
different in TPDKO mice. Whereas responses of mucosal and serosal class afferents to 
mechanical probing were unaffected, responses of muscular (but not muscular/mucosal) afferents 
to stretch were significantly attenuated in TPDKO mice as was sensitization by inflammatory 
soup of both muscular and muscular/mucosal afferents. In pharmacological studies, the TRPV1 
antagonist A889425 and P2X3 antagonist TNP-ATP, alone and in combination, applied onto 
stretch-sensitive afferent endings attenuated afferent responses to stretch; combined antagonism 
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 v 
produced greater attenuation. In the aggregate, these observations suggest that: (1) genetic 
manipulation of TRPV1 and P2X3 leads to reduction in colorectal mechanosensation 
peripherally and compensatory changes and/or disinhibition of other channels centrally and (2) 
combined pharmacological antagonism produces more robust attenuation of mechanosensation 
peripherally than single antagonism. The relative importance of these channels appears to be 
enhanced in hypersensitivity, highlighting the potential utility of multi-target pharmacotherapy in 
IBS. 
 vi 
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1.0  GENERAL INTRODUCTION 
Portions of this thesis have been presented in abstract form, including:  
 
Kiyatkin ME, Gebhart GF. “Role of TRPV1 and P2X3 in mechanosensation in colorectal 
primary afferents.” Program No. 473.05. 2012 Neuroscience Meeting Planner. 
Washington, DC: Society for Neuroscience, 2012. Online.  
 
Kiyatkin ME, Feng B, Schwartz ES, Gebhart GF. “Contribution of TRPV1 and P2X3 to 
mechanosensation in colorectal primary afferents in naive and sensitized states.” 14th 
World Congress on Pain. Milan, Italy: International Association for the Study of Pain, 
2012. 
 
Kiyatkin ME, Feng B, Gebhart GF. “TRPV1 and P2X3 are important mediators of 
mechanotransduction and sensitization in colorectal primary afferents.” Program No. 
494.06. 2011 Neuroscience Meeting Planner. Washington, DC: Society for Neuroscience, 
2011. Online. 
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2.0  DUAL INHIBITION OF TRPV1 AND P2X3 ATTENUATES COLORECTAL 
PRIMARY AFFERENT MECHANOSENSATION AND SENSITIZATION 
2.1 INTRODUCTION 
Chronic abdominal pain is a key feature of irritable bowel syndrome (IBS), which is prevalent, 
costly and difficult to manage. An important contributor to pain in IBS is heightened perception 
of mechanical events in the bowel (i.e., hypersensitivity). Indeed, patients with IBS typically 
report greater pain with colorectal distension (Ritchie, 1973; Lembo et al., 1994; Mertz et al., 
1995; Trimble et al., 1995; Bouin et al., 2002). Although central processes contribute to 
colorectal hypersensitivity, the driving force is increased afferent mechanosensitivity (i.e., 
sensitization). In support, intra-rectal lidocaine reduces pain evoked by colorectal distension in 
healthy subjects as well as ongoing pain and both visceral and somatic (referred) hypersensitivity 
in IBS patients (Plourde et al., 1993; Lembo et al., 1994; Verne et al., 2003; Verne et al., 2005). 
Accordingly, developing drugs that selectively attenuate colorectal mechanosensation and/or 
sensitization would improve management of IBS pain. Targets include ion channels expressed in 
colorectal afferents, two of which are transient receptor potential vanilloid 1 (TRPV1) and P2X3.  
TRPV1 is a capsaicin-, heat- and proton-gated ion channel expressed in the majority of 
colorectal afferents (Robinson et al., 2004; Christianson et al., 2006). Expression of TRPV1 in 
colorectal afferents is increased in patients with IBS (Akbar et al., 2008) and the magnitude of 
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channel expression often positively correlates with the severity of sensory symptoms.  We 
previously demonstrated that TRPV1 knockout mice show reduced responses of stretch-sensitive 
afferents (Jones et al., 2005) and decreased behavioral responses to colorectal distension (CRD) 
(Jones et al., 2007) in both naive and hypersensitive states. TRPV1 antagonists similarly 
decrease afferent and behavioral responses to CRD (Miranda et al., 2007; De Schepper et al., 
2008; Phillis et al., 2009; Wiskur et al., 2010). 
P2X3 exists in homomeric P2X3 and heteromeric P2X2/3 configurations and is 
expressed in ~20% of colorectal afferents (Brierley et al., 2005; Shinoda et al., 2010). Both 
configurations are activated via pressure-dependent mucosal release of ATP (Wynn et al., 2003; 
Shinoda et al., 2009), which facilitates distension-evoked mechanosensation (Wynn et al., 2003). 
In agreement, we found that deletion of P2X3 attenuates colorectal mechanosensation and 
sensitization (Shinoda et al., 2009). Further, the expression and function of P2X3 is enhanced in 
rodent models of IBS (Xu et al., 2008; Shinoda et al., 2010). 
Appreciating it to be unlikely that a single channel mediates colorectal pain and 
hypersensitivity, we hypothesized that combined inhibition of these channels should produce 
greater attenuation of mechanosensation than inhibition of either channel alone. To test this 
hypothesis, we utilized TRPV1-P2X3 double knockout (TPDKO) mice together with selective 
pharmacological antagonists to evaluate (1) channel contributions to colorectal nociception and 
hypersensitivity in vivo and (2) afferent mechanosensation and sensitization in vitro. Portions of 
these data have been previously reported in abstract form (Kiyatkin and Gebhart, 2012). 
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2.2 MATERIALS AND METHODS 
2.2.1 Animals 
Adult male mice (20-30 g) of the following strains were used: C57BL/6 wildtype control 
(Taconic, Germantown, NY) and global, non-conditional TPDKO.  TPDKO mice were 
generated by crossing TRPV1 and P2X3 single knockout mice.  All knockout mice were 
backcrossed onto a Taconic C57BL/6 genetic background for >10 generations. TRPV1 single 
knockout mice were provided by Dr. H. R. Koerber, the University of Pittsburgh. P2X3 single 
knockout mice were obtained from The Jackson Laboratory (Bar Harbor, ME) with the 
permission of Dr. D. A. Cockayne, Roche Bioscience, Palo Alto, CA. Genotypes were confirmed 
by PCR and Southern Blot analysis. We used only homozygous TPDKO mice. All protocols 
were approved by the University of Pittsburgh Institutional Animal Care and Use Committee. 
2.2.2 Labeling, single cell PCR, and calcium-imaging of colorectal neurons 
Dorsal root ganglion (DRG) sensory neurons innervating the colorectum were labeled and 
collected as previously detailed (Shinoda et al., 2010; Schwartz et al., 2011). Briefly, a 
laparotomy was performed on mice anesthetized with isoflurane (Hospira Inc., Lake Forest, IL) 
to expose the distal colon. Three to six boluses (2-3 µL) of 2% by weight 1,1’-dioctadecyl-
3,3,3’,3-tetramethylindocarbocyanine methanesulfonate (DiI; Molecular Probes, Eugene, OR) 
dissolved in DMSO were injected into the colon wall ~1.5 cm rostral to the anal verge. Mice 
were allowed two weeks for post-surgical recovery and transport of DiI to DRG somata. 
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Subsequently, mice were overdosed with isoflurane followed by removal of L6-S2 (LS) 
DRGs bilaterally.  DRGs were incubated at 37°C for 10 min in Hanks’ Balanced Salt solution 
(Sigma-Aldrich, St. Louis, MO) containing L-cysteine (5.5 mM), papain (60 Units; Worthington 
Biochemical, Lakewood, NJ) and saturated NaHCO3 (2 mM). Collagenase II (4,320 U; 
Worthington) and dispase II (14 U; Roche Diagnostics, Indianapolis, IN) were added and cells 
incubated for an additional 20 min before quenching enzyme activity with 10% fetal bovine 
serum (Sigma) dissolved in advanced Dulbecco’s modified eagle medium/F12 containing 1% 
penicillin/streptomycin (Invitrogen, Carlsbad, CA). The cell mixture was gently triturated, cells 
plated on poly-D-lysine-coated glass coverslips (Becton Dickinson Labware, Bedford, MA) and 
incubated (37°C, 95% O2) for 16-18 hours before beginning experiments. No additional growth 
factors were added to culture media. Two to three mice were used per preparation. 
Dissociated and cultured colorectal DRG neurons (c-DRGs) were identified by DiI 
content, collected with a ~50 µm diameter glass pipette and expelled into tubes containing 
reverse transcriptase (RT) mix (SuperScript II; Invitrogen). Negative controls were prepared by 
omitting RT. The first-strand cDNA was used as template for PCR (equipment and reagents from 
Promega, Madison, WI). We used a nested primer strategy with external primers for the first 
round of PCR followed by subsequent PCR with internal primers. Primer sequences are listed in 
Table 1. Final PCR products were electrophoresed and visualized on 2% agarose–ethidium 
bromide gels. 
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Table 1: Primer pairs for PCR amplification of TRPV1 and P2X3 mRNA. Single cell PCR 
was performed in dissociated colorectal afferent somata from LS DRGs. A nested PCR strategy 
with external and internal cDNA primer pairs was used to amplify reverse transcribed TRPV1 
and P2X3 mRNA. Sequences for cDNA primers are indicated with the 5’ end on the left. The 
Genebank reference used for designing primers is indicated at the right. bp, base pairs. 
 
 
Gene 
(expected size) 
External primers Internal primers Genebank 
Number 
TRPV1 
(486, 191 bp) 
GGGAAGAATAACTCACTGCCTGTG 
TGGGTCCTCGTTGATGATGC 
GGCGAGACTGTCAACAAGATTGC 
TCATCCACCCTGAAGCACCAC 
NM_001001
445.1 
P2X3 
(251, 141 bp) 
GCTCCGTAGAAGAAGATGGAGA 
CTGTGTGACCATGTTAGGGATG 
TGTCCTAAGAGGATCCTGTACC 
GGCATCTAGCACATAGAAGTGG 
NM_145526 
 
 
 
Other c-DRGs were loaded with 2.5 µM of the fluorescent Ca2+ indicator fura-2 acetoxymethyl 
and 0.025% pluronic acid (both from TEF Laboratories, Austin, TX) as detailed previously (Lu 
et al., 2006). Treated cells were transferred to a recording chamber continuously perfused with 
bath solution containing (in mM): 130 NaCl, 3 KCl, 2.5 CaCl2, 0.6 Mg Cl2, 10 HEPES, 10 
glucose and pH adjusted with Tris base to 7.4 and osmolarity with sucrose to 325 mOsmol/l. 
Ca2+-transients were measured as the ratio of fluorescence emission (510 nm) in response to 
340/380 nm excitation controlled by a lambda 10-2 filter changer (Sutter Instruments CA). Data 
were acquired using Metafluor software (Molecular Devices, Sunnyvale, CA) and a CCD camera 
(Model RTE/CCD 1300; Roper Scientific, Trenton, NJ). DiI-positive c-DRGs were stimulated in 
the following sequence: KCl (30 mM KCl in normal bath with 100 mM NaCl to maintain 
osmolarity), the P2X3 agonist α,β-meATP (100 µM in normal bath; Sigma), and the TRPV1 
agonist capsaicin (500 nM in normal bath and <0.01% ethanol; Sigma). All drugs were delivered 
via a fast-step superfusion system (Model DAD-12; ALA Scientific Instruments, Westbury, NY). 
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2.2.3 Colorectal distension (CRD) 
The visceromotor response (VMR) to CRD was measured to assess colorectal nociception and 
hypersensitivity (Christianson and Gebhart, 2007).  Briefly, mice were anesthetized (isoflurane) 
and a pair of electrodes implanted into the abdominal musculature and exteriorized at the back of 
the neck for subsequent electromyographic recording of muscle activity in unanesthetized mice. 
Contraction in response to CRD was quantified with Spike2 software (Cambridge Electronic 
Design, Cambridge, UK) as electromyographic activity during distension minus pre-distension 
resting activity. Polyethylene distension balloons (1.5 cm length, 0.9 cm diameter) were inserted 
transanally 1 cm beyond the anal verge under isoflurane sedation. Mice were placed inside 
darkened, sound-attenuated plastic cylinders to minimize movement and stress. A 45-min post-
isoflurane recovery period preceded CRD. Distension balloons were inflated for 10-s with 
pressurized nitrogen to 15, 30, 45 or 60 mmHg. Each pressure was tested three times with 4 min 
between distensions, starting at 15 mmHg (non-noxious) and ending at 60 mmHg (noxious). 
Baseline VMRs were recorded four days after surgery (Day 0) after which intracolonic treatment 
with either 0.1 mL of normal saline vehicle or zymosan (30 mg/mL; Sigma) was given and 
repeated daily for two additional consecutive days; VMRs to CRD were recorded again one day 
after the third intracolonic treatment (i.e., Day 3) (Shinoda et al., 2009). Some TPDKO mice 
were sacrificed after Day 3 CRD for single fiber electrophysiology (described below). 
2.2.4 Single fiber electrophysiology 
Mice were sacrificed by CO2 inhalation and the distal 2-3 cm of the colorectum was dissected 
out with the pelvic nerve (PN) innervation intact (Feng and Gebhart, 2011). Dissection was 
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performed in ice-cold oxygenated Krebs solution containing 4 µM nifedipine (L-type Ca2+ 
channel blocker to inhibit spontaneous muscle contraction; Sigma) and 3 µM indomethacin (to 
inhibit cyclooxygenase; Sigma). The dissected colon-nerve preparation was isolated and 
continually perfused with 31-33°C Krebs solution. The colorectum was opened longitudinally 
along the anti-mesenteric border and pinned mucosal side up. The PN was threaded into a 
separate oil-filled recording chamber and progressively teased apart into 6-10 bundles (~10 µm 
thick) to isolate single fibers (>3:1 signal-to-noise ratio). Recordings were made by laying 
bundles atop a platinum-iridium wire extracellular electrode ~100mm in diameter. Neural 
activity was amplified (10,000-fold; DAM80, World Precision Instruments, New Haven, CT), 
filtered (0.3- 10 kHz) and sampled (20 kHz) using a 1401 interface (CED) and Spike2. 
An electrical search strategy was used for unbiased detection of all excitable afferent 
receptive endings (REs) and measurement of their electrical activation thresholds (Feng and 
Gebhart, 2011). All REs were tested for mechanosensitivity as follows: mucosal stroking with a 
fine brush producing ~0.1 mN of perpendicular force; blunt perpendicular probing (1-80 mN; 5-s 
duration) and uniform circumferential stretch (0-170 mN, equivalent to 45 mmHg CRD; Feng et 
al., 2010) applied as a ramp (5 mN/s, 34 s) or fast-step (to 80 or 170 mN in 0.2 s). Probing and 
stretching were performed using a servo-controlled force actuator (Aurora Scientific, Toronto, 
ON). Colorectal PN afferents were classified as previously described (Feng and Gebhart, 2011). 
Briefly, all REs responded to blunt probing except mechanically insensitive afferents (MIAs). 
Muscular afferents also responded to stretch, mucosal afferents also to stroking and 
muscular/mucosal afferents also to stretch and stroking. Serosal afferents responded only to 
probing. On average, 1-6 fibers were studied per mouse. 
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Agonists, antagonists and a sensitizing inflammatory soup (IS) were applied directly atop 
isolated REs (Feng et al., 2010). Inflammatory soup was composed of bradykinin, prostaglandin 
E2, serotonin and histamine (all at 10µM) with pH adjusted to 6.0 (Jones et al., 2005). IS was 
applied for 3-min followed by mechanical testing 3 min later and then every 5 min until washout 
(i.e., return to baseline). Channel antagonists were applied for 5-min followed immediately by 
mechanical testing repeated every 5 min until washout. In our hands, a 5 min inter-test interval is 
sufficient for full recovery of fiber response to mechanical stimulation. To inhibit TRPV1, we 
utilized A889425 (Abbott Laboratories, Abbott Park, IL), a highly selective competitive 
antagonist for the capsaicin-binding site with an IC50 of ~300nM (McGaraughty et al., 2008; 
Brederson et al., 2011). A889425 was dissolved in 1-methyl-2-pyrrolidinone (1M2P) and diluted 
to final concentration (1%) with Krebs solution; solvent control experiments revealed no 
significant effect of 1% 1M2P on fiber mechanosensitivity (see Fig. 6 for reference). P2X3 was 
inhibited with TNP-ATP (Sigma), a competitive antagonist for P2X1, P2X3 and P2X2/3 with an 
IC50 of ~30nM (Gever et al., 2006). The TRPV1 agonist capsaicin (3µM in Krebs and <0.01% 
ethanol) and P2X agonist α,β-meATP (1mM in Krebs) (Brierley et al., 2005; Feng and Gebhart, 
2011) were applied for 2-min and removed sooner if activation occurred to minimize afferent 
desensitization. Agonist application was followed immediately by mechanical testing as 
described above. 
2.2.5 Statistics 
Data are presented as mean ± SEM. Responses to CRD, probing and ramped stretch are 
presented as stimulus-response functions. For ramped stretch, stimulus-response functions are 
presented as binned counts during stretch (0-53, 53-113 and 113-170 mN). To compare CRD and 
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single fiber stimulus-response functions before and after treatment, responses at each pressure or 
force were normalized to the pre-treatment response at the final pressure (60 mmHg) or force 
(113-170 mN). Data were analyzed using one or two-way ANOVAs (Holm- Sidak post-hoc 
tests), paired or unpaired Student’s t-tests or Fischer’s exact test (SigmaPlot 9, Systat Software, 
San Jose, CA) as appropriate. Single fiber spontaneous activity was rare and, when present, was 
subtracted from stimulus-evoked activity. P<0.05 was considered statistically significant. 
2.3 RESULTS 
2.3.1 Co-expression of TRPV1 and P2X3 
As detailed in Table 2, the majority of LS c-DRGs from C57BL/6 control mice co-expressed 
mRNA for TRPV1 and P2X3. The proportion of c-DRGs that expressed TRPV1 mRNA closely 
paralleled the proportion of neurons that responded to capsaicin (500 nM). About a third of these 
capsaicin-sensitive neurons also responded to α,β-meATP (100 µM). In contrast, only a minority 
of c-DRGs responded to α,β-meATP, but the majority of these neurons also responded to 
capsaicin. 
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Table 2: Expression of TRPV1 and P2X3 mRNA and response to channel agonists in 
lumbosacral colon sensory neurons. A total of 14 LS c-DRGs including one control from one 
preparation were tested for mRNA expression. A total of 31 LS c-DRGs from two preparations 
were examined for Ca2+-transient responses to α,β-meATP (100 µM) followed by capsaicin (500 
nM). For Ca2+-imaging, only cells that initially responded to 30 mM KCl were treated with 
agonists. 
 
 
 mRNA expression  Response to channel agonists 
 % n  % n 
TRPV1 only 77% (10/13)  74% (23/31) 
P2X3 in TRPV1 positive neurons 80% (8/10)  30% (7/23) 
P2X3 only 85% (11/13)  35% (11/31) 
TRPV1 in P2X3 positive neurons 67% (8/11)  64% (7/11) 
 
2.3.2 Response to colorectal distension 
C57BL/6 and TPDKO mice responded similarly to CRD (Fig. 1A). However, responses were 
significantly greater in TPDKO mice, most apparent at noxious intensities of CRD (i.e., 45 and 
60 mmHg). Intracolonic treatment with saline had no effect on responses to CRD in either 
genotype whereas treatment with zymosan elicited significant colorectal hypersensitivity in 
C57BL/6 (as previously reported; e.g., Feng et al., 2010) but not TPDKO mice (Fig. 1B-C).  
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Figure 1:  Visceromotor responses to colorectal distension. (A) Relative to C57BL/6 controls, 
TPDKO mice exhibited greater baseline responses to CRD (F1/144=5.8, p<0.05, Holms-Sidak 
post-hoc tests, p<0.01 at 45 and 60 mmHg CRD). (B) Intracolonic zymosan, but not saline, 
produced colorectal hypersensitivity in C57BL/6 mice (F1/24=6.4, p<0.05), but not in TPDKO 
mice (C). Visceromotor responses (not normalized) were used to generate stimulus-response 
curves in panel A; normalized responses were used for panels B-C. n, number of mice/group. 
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2.3.3 Characterization of colorectal afferent fibers 
To explore the contributions of PN afferents to the CRD phenotype and to study in detail the 
effects of combined ablation of TRPV1 and P2X3 on colorectal afferent mechanosensation, we 
compared classes of afferents in C57BL/6 and TPDKO mice. Neither the proportions nor the 
electrical activation thresholds of the five classes of PN afferents differed between the two 
genotypes (Fig. 2). However, relative to control mice, there was a tendency in TPDKO mice for 
mucosal and muscular/mucosal afferent REs to be topographically shifted to and concentrated in 
the distal 1 cm of the colorectum. There were no other differences in topographical distributions 
of PN afferents between genotypes.  
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Figure 2: Proportions and electrical activation thresholds of colorectal afferent fibers. Co-
deletion of TRPV1 and P2X3 (i.e., TPDKO) had no effect on (A) proportions or (B) electrical 
activation thresholds of PN colorectal afferents.  A total 116 fibers were studied from 23 
C57BL/6 mice and 102 fibers from 24 TPDKO mice. musc, muscular; mucos, mucosal; M/M, 
muscular/mucosal; MIA, mechanically-insensitive afferent. 
 
 
 
Serosal and mucosal REs in both genotypes gave similar responses to probing (Fig. 3A-B). 
Likewise, there was no difference in response to probing between stretch-sensitive muscular and 
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muscular/mucosal afferents (Fig. 3C-D). As noted previously (e.g., Feng et al., 2012), responses 
of muscular afferents to stretch in C57BL/6 mice were generally more robust than responses of 
their muscular/mucosal afferent counterparts. In TPDKO mice, responses of muscular (Fig. 4A), 
but not muscular/mucosal afferents (Fig. 4B) to stretch were significantly attenuated relative to 
C57BL/6 mice. Responses to the fast-step stretch protocol did not reveal any genotype 
differences between muscular and muscular/mucosal afferents (Fig. 4C-D). 
 
 
 
 
 
Figure 3: Responses of colorectal afferent fibers to perpendicular probing. Co-deletion of 
TRPV1 and P2X3 (i.e., TPDKO) had no effect on colorectal afferent responses to blunt probing 
of receptive endings. Stimulus-response curves are presented for serosal (A), mucosal (B), 
muscular (C) and muscular/mucosal (D) afferents.  n, number of fibers/group. 
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Figure 4: Responses of colorectal afferent fibers to circumferential stretch. Responses of (A) 
muscular, but not (B) muscular/mucosal, afferents to circumferential stretch (0-170 mN, 5 
mN/sec) were reduced in TPDKO relative to C57BL/6 mice (F1/180=11.8, p<0.001). Response 
thresholds (insets) were increased in muscular (t=4.3, p<0.001), but not muscular/mucosal, 
afferents. (C-D) Responses of muscular and muscular/mucosal afferents to stepped stretch (0.2 s 
rise time) did not differ between genotypes. n, number of fibers/group. 
 
 
 
We next examined IS-induced sensitization of stretch-sensitive afferents. IS significantly 
increased stretch-response functions and decreased response thresholds (i.e., sensitized) of 
muscular and muscular/mucosal afferents in both C57BL/6 and TPDKO mice (Fig. 5). However, 
both muscular and muscular/mucosal afferents sensitized to a significantly lesser degree in 
TPDKO than C57BL/6 mice. All fibers tested, regardless of genotype, were also activated by IS, 
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revealing RE chemosensitivity; recovery (washout) was typically complete in both genotypes 
within ~20 min after IS.  Single fiber recordings were also performed in TPDKO mice treated 
intracolonically with saline (36 fibers from 4 mice) or zymosan (26 fibers from 5 mice). There 
were no differences in either proportions of colorectal afferent classes or sensitization of afferent 
fiber responses between saline- and zymosan-treated mice (data not shown), consistent with the 
absence of colorectal hypersensitivity in these same mice (Fig. 1C).  
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Figure 5: Inflammatory soup-induced sensitization of colorectal afferents fibers. Co-
deletion of TRPV1 and P2X3 (i.e., TPDKO) attenuated IS-induced sensitization of stretch-
sensitive colorectal afferents. (A) IS sensitized stretch-response functions of muscular afferents 
from C57BL/6 (F1/16=9.5, p<0.05) and TPDKO mice (F1/24=6.6, P<0.05). IS also decreased 
response thresholds (inset; n.s., not significant) in C57BL/6 (paired t-test comparing post-IS 
thresholds normalized to pre-IS thresholds [threshold, %]: t=6.7, p<0.001) and TPDKO mice 
(t=2.8, p<0.05). (B) IS sensitized muscular/mucosal afferents in both C57BL/6 (F1/18=37.0, 
p<0.001) and TPDKO mice (F1/16=8.6, p<0.05).  Afferent response thresholds were equally 
decreased after IS (inset) in both C57BL/6 (t=7.3, p<0.001) and TPDKO mice (t=3.5, p<0.05). n, 
number of fibers/group. The magnitude of sensitization was significantly less in TPDKO mice in 
both muscular (A; p<0.05) and muscular/mucosal (B; p<0.001) afferents relative to the 
sensitization produced in afferents recorded from C57BL/6 mice. 
 
2.3.4 Pharmacological antagonism of TRPV1 and P2X3 
The efficacy of the TRPV1 antagonist A889425 varied considerably and effects on responses of 
stretch-sensitive afferents were not apparent at all concentrations tested; 300nM was most 
effective in reducing responses of muscular afferents to stretch and 3µΜ most effective in 
 19 
reducing responses of muscular/mucosal afferents (Fig. 6A-B).  Because of variability in 
responses to stretch after exposure to vehicle and because TRPV1 is not expressed in all 
colorectal afferents (Table 2), we set as an effect criterion a reduction ≥15% post-treatment in 
afferent response to stretch. Using this criterion (denoted by >15 in Figs. 6 & 7), ~65% of both 
muscular (9/14) and muscular/mucosal (8/12) afferents exhibited a significant reduction in their 
response to stretch after treatment with 300nM and 3µΜ A889425, respectively. To 
pharmacologically probe TRPV1 expression in these experiments, we applied capsaicin (3µΜ) to 
eight of the above stretch-sensitive afferents after multiple exposures to A889425.  Although 
washout after A889425 was apparent within ~10 min (i.e., responses to stretch returned to 
baseline) in the majority of afferents tested, application of capsaicin to REs failed to excite any 
of the REs tested, but did increase response threshold in 6/8 afferents tested.  In contrast to the 
effect of capsaicin on response threshold, response thresholds were unaffected by A889425, with 
or without the effect criterion invoked (Fig 6C-D). 
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Figure 6: Antagonism of TRPV1 attenuated mechanosensitivity of stretch-sensitive 
colorectal afferents. (A) Relative to vehicle (1% 1M2P), A889425 did not significantly decrease 
stretch-response functions of muscular afferents at any concentration tested, although 300nM 
reduced responses to ~60%.  Application of an effect criterion of ≥15% post-treatment reduction 
of stretch-responsive functions (9/14 fibers; ~65% of total) revealed significant attenuation by 
300nM A889425 of response to stretch (F3,120=8.9, p<0.01, post-hoc comparison, p<0.01). (B) 
3µM A889425 significantly attenuated muscular/mucosal stretch-response functions relative to 
vehicle (F3,117=2.9, p<0.05, post-hoc comparison, p<0.05).  Application of the effect criterion as 
above (8/12 fibers; ~65%) similarly yielded significant attenuation by 3µM A889425 of response 
to stretch (F3,105=4.8, p<0.05, post-hoc comparison, p<0.05). (C-D) Response thresholds of 
muscular and muscular/mucosal afferents, with or without application of the effect criterion, 
were unaffected by A889425.  For statistical analyses, responses post-A889425 were compared 
against responses post-1M2P, which were compared against their respective pre-drug baselines. 
n, number of fibers/group. >15% denotes application of response criterion.   
 
 
 
Compared with vehicle (Krebs solution), 30 - 300nM, 1 and 3µΜ concentrations of the P2X 
antagonist TNP-ATP did not attenuate responses of either muscular or muscular/mucosal 
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afferents to stretch (Fig. 7A-B). Applying the same effect criterion as above, approximately 35% 
of both muscular and muscular/mucosal afferents demonstrated a ≥15% decrease in their 
stimulus-response functions after exposure to 3µΜ and 300nM TNP-ATP, respectively. At these 
concentrations, TNP-ATP significantly attenuated responses to stretch in both muscular and 
muscular/mucosal afferents. As above with capsaicin, we attempted to pharmacologically 
establish P2X expression by application of α,β-meATP after multiple exposures to TNP-ATP; 
6/13 REs tested exhibited an apparent increase in response to stretch. In contrast to the TRPV1 
antagonist, TNP-ATP significantly increased response thresholds of muscular/mucosal afferents 
(Fig. 7D).  Antagonist washout was apparent within ~10 min in all muscular and most 
muscular/mucosal afferents tested.  
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Figure 7: Antagonism of P2X3 attenuated mechanosensitivity in stretch-sensitive colorectal 
afferents. (A) Relative to pre-treatment baseline, TNP-ATP had no effect on stretch-response 
functions in muscular afferents; application of the ≥15% effect criterion (4/13 fibers; ~31%) 
revealed a significant effect at the 3µM concentration (F3,111=2.9, p<0.05, post-hoc comparison, 
p<0.05). (B) TNP-ATP did not affect muscular/mucosal afferent stretch-response functions, but 
application of the effect criterion (6/15 fibers; 40%) revealed a significant effect of 300nM TNP-
ATP (F3,81=5.5, p<0.01, post-hoc comparison, p<0.05).  (C) TNP-ATP did not affect response 
thresholds of muscular afferents, but (D) did increase response thresholds of muscular/mucosal 
afferents without (F2,34=6.3, p<0.01, post-hoc comparison, p<0.01) as well as with (F2,21=4.8, 
p<0.05, post-hoc comparison, p<0.05) the effect criterion invoked. n, number of fibers/group; 
TNP, abbreviation for TNP-ATP. >15% denotes application of response criterion. 
 
 
 
In another group of 11 stretch-sensitive afferent endings, we tested combined pharmacological 
antagonism with A889425 plus ATP-TNP at the most effective concentrations determined above 
(300nm and 3µΜ) and also applied the TRPV1 and P2X3 agonists capsaicin (3µΜ) and α,β-
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meATP (1mM), respectively.  Four/11 responded to both agonists, five responded to neither 
agonist and the remainder responded to one but not the other agonist. Interestingly, afferents 
responding to both TRPV1 and P2X3 agonists showed significantly higher response thresholds 
to stretch than those responding to neither agonist (71.5±9.1 vs. 21.1±1.6 mN, t-test, p<0.001). 
Combined antagonist application did not affect responses to stretch in those five afferents that 
did not respond to either agonist (Fig. 8A).  Co-antagonism with A889425 and TNP-ATP, 
however, significantly attenuated responses to stretch in those four afferents that responded to 
both agonists (Fig. 8B). 
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Figure 8: Combined antagonism of TRPV1 and P2X3 attenuated mechanosensitivity of 
stretch-sensitive muscular and muscular/mucosal colorectal afferents. (A) Combined 
A889425 and TNP-ATP application to afferent endings that did not respond to either capsaicin 
(cap) or α,β-methylene ATP (α,βmATP) was without effect on responses to stretch whereas (B) 
combined A889425 and TNP-ATP application to afferent endings that responded to both cap and 
α,βmATP significantly attenuated responses to stretch (F2,27=7.1, P=0.003, post-hoc comparison, 
P=0.007 vs. control). For purposes of comparison, muscular and muscular/mucosal stretch-
sensitive afferents that met the response criterion (i.e., >15%) were pooled from Figures 6A and B 
(A889425) and 7A and B (TNP-ATP) and illustrated here in half-tone. Combined antagonism 
produced a significantly greater attenuation in response than TNP-ATP alone (F1,36=7.7, p<0.01) 
and a lower response than A889425 alone (borderline significant, F1,57=3.6, P=0.06).  
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2.4 DISCUSSION 
In agreement with previous studies in rat lumbar DRG neurons (Guo et al., 1999; Ueno et al., 
1999; Stanchev et al., 2009), the present work demonstrates that a substantial proportion of 
mouse PN colorectal afferents co-express TRPV1 with P2X3. Previously, we reported deficits in 
colorectal mechanosensation and sensitization with single deletion of either TRPV1 or P2X3 
(Jones et al., 2005; Jones et al., 2007; Shinoda et al., 2009). Given the co-expression reported 
here and elsewhere, we expected similar, if not greater, effects in TRPV1-P2X3 double knockout 
mice. As expected, colorectal hypersensitivity did not develop in TPDKO mice, consistent with 
the absence of afferent fiber sensitization in zymosan-treated mice and the significantly reduced 
sensitization by IS of stretch-sensitive afferents. Unexpectedly, basal responses to CRD were 
greater in TPDKO than C57BL/6 mice despite significantly reduced responses of muscular 
afferents to stretch and unchanged responses of other afferent classes in TPDKO mice, 
suggesting enhanced central processing. Greater mechanosensation may be due to disinhibition 
or compensatory overexpression of ion channels such as TRPV4 or TRPA1 in the peripheral 
and/or central terminals of primary afferents or in second order spinal neurons. 
Of the two channels studied, P2X3 may be most contributory to the greater response to 
CRD in TPDKO mice because P2X3 single knockout mice have been reported to exhibit pro- 
nociceptive behaviors, including enhanced avoidance of noxious thermal stimuli (Shimizu et al., 
2005). An alternate explanation is the redistribution we noted in TPDKO mice of mucosal and 
muscular/mucosal afferent endings to the distal 1 cm of the colorectum. In our experience, 
greater visceromotor responses to CRD are evoked with more distal positioning of the distension 
balloon. In support, PN afferents in the distal colorectum exhibit greater mechanosensitivity than 
their more proximal counterparts (Feng et al., 2010). Because the proportions of each class of 
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afferent were the same in both genotypes, this caudal transposition in TPDKO mice was unlikely 
a result of conversion of one class of afferent into another. In support, there were no significant 
differences between genotypes with respect to probing- response functions of any type of 
afferent. 
Co-deletion of TRPV1 and P2X3 reduced responses of muscular afferents to stretch, but 
had no effect on muscular/mucosal afferents. Responses of muscular and muscular/mucosal 
afferents to stretch in P2X3-null mice did not differ from responses in C57BL/6 mice (Shinoda et 
al., 2009), suggesting that central mechanisms contributed to the reduced responses to CRD 
noted in these mice. In contrast, responses of muscular/mucosal afferents to stretch in mice 
lacking TRPV1 were significantly attenuated relative to C57BL/6 mice; responses of muscular 
afferents were ~twice those of control, but not statistically significant (Jones et al., 2005). 
Collectively, it appears that deletion of either TRPV1 or P2X3 alone does not alter net peripheral 
input from PN afferents in response to stretch whereas co-deletion of both channels results in a 
net decrease in peripheral input from stretch-sensitive afferents. 
The TRPV1 antagonist A889425 significantly attenuated responses of muscular and 
muscular/mucosal afferents to stretch in C57BL/6 mice. Consistent with previous (Christianson 
et al., 2006) and current (Table 2) reports of TRPV1 expression in 60-70% of mouse colorectal 
afferents, A889425 was not uniformly effective on all stretch-sensitive afferents. Baseline 
mechanosensitivity of A889425-sensitive afferents did not differ from A889425-insensitive 
afferents, in contrast to a previous report of higher mechanical thresholds in TRPV1-expressing 
colorectal afferents (Malin et al., 2009). TNP-ATP was not as broadly effective as A889425 on 
stretch-sensitive afferents; fewer afferent responses met the effect criterion (≥15% reduction), 
but those that did exhibited attenuated responses to stretch. TNP-ATP did increase response 
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thresholds in muscular/mucosal afferents, supporting the view that P2X3 and P2X2/3 are 
important primarily for the initiation, not maintenance, of nociception (Hamilton et al., 2000). In 
support of a greater role of P2X3 in muscular/mucosal versus muscular afferent 
mechanosensation and the P2X3 expression proportions reported here (Table 2) and elsewhere 
(Brierley et al., 2005; Shinoda et al., 2010), ~30% of muscular and ~45% of muscular/mucosal 
afferents were activated by α,β-meATP. Similar proportions of muscular (~30%) and 
muscular/mucosal (40%) afferents met the TNP-ATP effect criterion. 
Combined antagonism of both channels significantly attenuated responses to stretch in 
afferents that responded to both agonists, but not responses of those afferents that did not 
respond to both agonists. The results suggest an additive if not greater than additive attenuation 
of responses to stretch by simultaneous antagonism of both channels. This functional interaction 
may be mediated through common Ca2+-dependent signaling cascades (Docherty et al., 1996; 
King et al., 1997; Rosenbaum et al., 2004; Xu and Huang, 2004; Price et al., 2005; Tsuda et al., 
2007) or modulatory conformational spread (Bray and Duke, 2004) via direct physical 
association of TRPV1 and P2X3 as demonstrated previously (Stanchev et al., 2009). 
To further explore the contributions of TRPV1 and P2X3 to colorectal afferent 
mechanosensation, we evaluated in TPDKO mice acute sensitization of stretch-sensitive 
afferents by IS. In TRPV1- and P2X3-null mice, IS sensitized muscular/mucosal, but not 
muscular afferents (Jones et al., 2005; Shinoda et al., 2009). In TPDKO mice, however, both 
afferent classes were sensitized by IS, although the magnitude of sensitization was significantly 
reduced relative to sensitization in C57BL/6 mice. Differences in outcomes between single and 
double knockout mice may be explained by compensatory changes in protein expression. In 
muscular/mucosal afferents, sensitization may cause upregulation or enhanced functioning of 
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TRPV1 and P2X3 (Hamilton et al., 1999) as well as other ion channels. Therefore, if only one 
channel is deleted, functioning of the remaining channel may be sufficiently enhanced after 
sensitization such that no loss-of-function phenotype occurs. Only when both channels are 
eliminated is a reduction in stretch-response functions manifest, and even then sensitization is 
still present. In muscular afferents, on the other hand, deletion of either or both TRPV1 and 
P2X3 is sufficient to produce a loss-of-function phenotype, suggesting that both channels are 
critical for mechanical sensitization in this class of afferent. 
We made several additional important observations. First, responses of muscular 
afferents to stretch were significantly attenuated in TPDKO mice, but responses to stepped 
stretch or probing were not. This suggests a stimulus-specific contribution of TRPV1 and/or 
P2X3 to afferent mechanosensation. It is possible that only slow-onset stimuli recruit these 
channels because this allows sufficient time for biochemical generation of ATP and endogenous 
lipid ligands of TRPV1 (Hwang et al., 2000; Scotland et al., 2004; Patwardhan et al., 2009). 
Second, TRPV1 and P2X3 appear to be more important for mechanosensation/sensitization in 
muscular/mucosal afferents than in other colorectal afferent classes. Coincidently, zymosan- 
induced hypersensitivity is associated with sensitization of muscular/mucosal afferents (Feng et 
al., 2012). Thus, TRPV1 and P2X3 may be important in the development and/or maintenance of 
zymosan-induced colorectal hypersensitivity and, by extension, IBS pain. Third, deletion of both 
channels abolished zymosan-induced recruitment of MIAs, which has been observed in C57BL/6 
mice (Feng et al., 2012). Considering that very few colorectal PN MIAs respond to capsaicin 
(Feng and Gebhart, 2011), our observation in TPDKO mice suggests that P2X3 may be 
important for mechanical sensitization of MIAs. 
In summary, the present study confirms the importance of TRPV1 and P2X3 for 
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colorectal mechanosensation and hypersensitivity at the levels of the whole organism and 
primary afferent. By evaluating inhibition of both channels simultaneously, this work also 
contributes to the growing appreciation of the functional interaction between distinct ion 
channels, which is not uncommon (e.g., TRPV1-TRPA1, Staruschenko et al., 2010, and P2X3- 
GABAA ,Toulme et al., 2007) and may prove important for guiding drug development. With 
regard to limitations, the single fiber work focused exclusively on PN colorectal afferents to 
build on previous studies in this same afferent population (Jones et al., 2005; Jones et al., 2007; 
Shinoda et al., 2009). Although the PN is necessary and sufficient for mediating colorectal 
nociception (Kyloh et al., 2011), the other source of extrinsic colorectal innervation – the lumbar 
splanchnic nerve (LuSN) – was not evaluated here. Because the LuSN pathway may be relevant 
for chemosensation (Brierley et al., 2005) and/or central sensitization (Traub, 2000), a TRPV1-
P2X3 interaction in LuSN afferents may reveal unexpected contributions to mechanosensation. 
The results in TPDKO mice are generally supportive of previous studies in single knockout mice 
as well as pharmacological antagonism. Differences in outcomes between single and double 
knockout mice could be due to functional redundancy of TRPV1 and P2X3 in some afferents and 
compensation in others. The relative importance of these channels appears to be enhanced in 
hypersensitivity, suggesting their importance in colorectal mechanosensation and the potential 
utility of combined pharmacological antagonism as a treatment for IBS pain and 
hypersensitivity. 
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